Jim Ryan Recognized as Top Deal-Making Attorney by Dallas Business Journal

April 3, 2017 | Attorney News

Attorney Jim Ryan honoree of Dallas Business JournalJackson Walker partner Jim Ryan has been named to Dallas Business Journal’s 2017 Dealmakers list. The list honors Dallas’ top M&A professionals, including attorneys, private equity broker-dealers, and investment bankers. The list was published in a special edition of the Dallas Business Journal and honorees will be recognized at an awards reception on April 5, 2017.

Honorees were chosen by a panel of Dallas Business Journal and Texas Lawbook editors for their deal-making accomplishments in a specific niche. Although Jim’s transactional practice spans several industries, he has significant experience in the healthcare industry.  In late 2015, he represented Dallas-based clients Questcare Medical Services, PA and QRx Medical Management, LLC in the $135 million sale of their business to Envision Healthcare Holdings, Inc. The deal covered more than 50 physician-owned healthcare facilities throughout Texas, Oklahoma, and Colorado.

This honor also recognizes Jim’s general accomplishments in mergers and acquisitions in 2016. Highlights of his work in 2016 include the representation of Blueknight Energy Partners L.P. (NASDAQ: BKEP) in their acquisition of nine asphalt terminals from Ergon Asphalt & Emulsions, Inc., a deal worth roughly $135.9 million.

For more information, explore Jackson Walker’s Corporate and Securities practice.

About Jim Ryan

James S. “Jim” Ryan, III is a seasoned corporate and securities attorney based in Jackson Walker’s Dallas office. He counsels clients on a wide range of transactional matters, including business acquisitions and divestitures, capital formation and investments, and joint ventures. His work has earned him various honors, including recognition in the Best Lawyers in Dallas list by D Magazine and Woodward/White Inc.’s The Best Lawyers in America list for Corporate Law (2008 – 2017) and Mergers & Acquisitions Law (2009 – 2017).